NDC 49643-118

Rhizopus

Rhizopus Oryzae

Rhizopus is a Cutaneous; Intradermal; Subcutaneous Injection in the Non-standardized Allergenic category. It is labeled and distributed by Allermed Laboratories, Inc.. The primary component is Rhizopus Arrhizus Var. Arrhizus.

• Product ID: 49643-118_4f1be4f6-9f9e-5c19-e054-00144ff8d46c
• NDC: 49643-118
• Product Type: Non-standardized Allergenic
• Proprietary Name: Rhizopus
• Generic Name: Rhizopus Oryzae
• Dosage Form: Injection
• Route of Administration: CUTANEOUS; INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1974-03-12
• Marketing Category: BLA / BLA
• Application Number: BLA102211
• Labeler Name: Allermed Laboratories, Inc.
• Substance Name: RHIZOPUS ARRHIZUS VAR. ARRHIZUS
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 49643-118-05

5 mL in 1 VIAL, MULTI-DOSE (49643-118-05)

• Marketing Start Date: 1974-03-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49643-118-10 [49643011810]

Rhizopus INJECTION

• Marketing Category: BLA
• Application Number: BLA102211
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-12

NDC 49643-118-50 [49643011850]

Rhizopus INJECTION

• Marketing Category: BLA
• Application Number: BLA102211
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-12

NDC 49643-118-05 [49643011805]

Rhizopus INJECTION

• Marketing Category: BLA
• Application Number: BLA102211
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-12

NDC 49643-118-30 [49643011830]

Rhizopus INJECTION

• Marketing Category: BLA
• Application Number: BLA102211
• Product Type: NON-STANDARDIZED ALLERGENIC
• Marketing Start Date: 1974-03-12

Drug Details

Active Ingredients

Ingredient	Strength
RHIZOPUS ARRHIZUS VAR. ARRHIZUS	.1 g/mL

Pharmacological Class

• Non-Standardized Fungal Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Fungal Proteins [Chemical/Ingredient]
• Allergens [Chemical/Ingredient]

NDC Crossover Matching brand name "Rhizopus" or generic name "Rhizopus Oryzae"

NDC	Brand Name	Generic Name
49288-0434	Rhizopus	Rhizopus
49288-0435	Rhizopus	Rhizopus
49643-118	Rhizopus	Rhizopus oryzae
22840-2619	Rhizopus oryzae	Rhizopus oryzae
22840-2620	Rhizopus oryzae	Rhizopus oryzae
22840-2621	Rhizopus oryzae	Rhizopus oryzae
22840-5633	Rhizopus oryzae	Rhizopus oryzae
36987-2073	Rhizopus oryzae	Rhizopus oryzae
36987-2074	Rhizopus oryzae	Rhizopus oryzae
36987-2075	Rhizopus oryzae	Rhizopus oryzae
36987-2076	Rhizopus oryzae	Rhizopus oryzae
36987-2077	Rhizopus oryzae	Rhizopus oryzae
36987-2078	Rhizopus oryzae	Rhizopus oryzae
36987-2079	Rhizopus oryzae	Rhizopus oryzae
36987-2080	Rhizopus oryzae	Rhizopus oryzae
36987-2081	Rhizopus oryzae	Rhizopus oryzae